A cohort study with a broad range of neurodegenerative diseases, including PSP, CBS, PD, PD with MCI, PDD, DLB, FTD, ALS, AD, and MCI, and healthy controls used ELISA to compare CSF NfL levels. This evidence concerns the gene CBS and neurodegenerative disease.